drugset / Trial / NCT05811975

KSX01-TCRT Injection Project in Solid Tumors

NCT05811975 ↗

Phase 0 Recruiting 50 enrolled TCRx Therapeutics Co.Ltd
NaSingle-groupOpen-labelTreatment

Summary

1\) Safety and efficacy of TCR-T cells in subjects with refractory/relapsed solid tumors. 2) The activation and proliferation of TCR-T cells in the subject, and the survival time.

Timeline

Start
2023-03-07
Primary completion
2026-12-31
Completion
2028-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject KSX01-TCRT Cell therapy — —